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Abstract
Background: Whole genome sequencing (WGS) has rapidly become an important research tool in tuberculosis
epidemiology and is likely to replace many existing methods in public health microbiology in the near future.
WGS-based methods may be particularly useful in areas with less diverse Mycobacterium tuberculosis populations,
such as New York City, where conventional genotyping is often uninformative and field epidemiology often
difficult. This study applies four candidate strategies for WGS-based identification of emerging M. tuberculosis
subpopulations, employing both phylogenomic and population genetics methods.
Results: M. tuberculosis subpopulations in New York City and New Jersey can be distinguished via phylogenomic
reconstruction, evidence of demographic expansion and subpopulation-specific signatures of selection, and by
determination of subgroup-defining nucleotide substitutions. These methods identified known historical outbreak
clusters and previously unidentified subpopulations within relatively monomorphic M. tuberculosis endemic clone
groups. Neutrality statistics based on the site frequency spectrum were less useful for identifying M. tuberculosis
subpopulations, likely due to the low levels of informative genetic variation in recently diverged isolate groups.
In addition, we observed that isolates from New York City endemic clone groups have acquired multiple
non-synonymous SNPs in virulence- and growth-associated pathways, and relatively few mutations in drug
resistance-associated genes, suggesting that overall pathoadaptive fitness, rather than the acquisition of drug
resistance mutations, has played a central role in the evolutionary history and epidemiology of M. tuberculosis
subpopulations in New York City.
Conclusions: Our results demonstrate that some but not all WGS-based methods are useful for detection of
emerging M. tuberculosis clone groups, and support the use of phylogenomic reconstruction in routine tuberculosis
laboratory surveillance, particularly in areas with relatively less diverse M. tuberculosis populations. Our study also
supports the use of wider-reaching phylogenomic and population genomic methods in tuberculosis public health
practice, which can support tuberculosis control activities by identifying genetic polymorphisms contributing to
epidemiological success in local M. tuberculosis populations and possibly explain why certain isolate groups are
apparently more successful in specific host populations.
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Background
Tuberculosis (TB) epidemiology in New York City has
undergone dramatic changes since the resurgent TB
epidemic of the 1990s, when over 3000 cases were
reported each year between 1991 and 1994, many in
outbreak clusters among vulnerable populations [1].
TB incidence is now at an all-time low (7.2 cases per
100,000 people in 2014) [2], outbreak clusters have
become increasingly rare, and so-called endemic
clones have become a major source of new TB infec-
tions in the US-born population [3, 4].
Genotyping of Mycobacterium tuberculosis (M. tuber-
culosis) clinical isolates is a cornerstone of TB control in
New York City. However, conventional genotyping
methods (including restriction length fragment poly-
morphism typing, spoligotyping, and mycobacterial
interspersed repetitive Units (MIRU) typing), interrogate
less than 0.01% of the approximately 4 MbM. tubercu-
losis genome and thus lack the discriminatory power to
detect small-scale genetic differences within closely
related populations. In these situations, genotyping will
often yield little if any useful information, even in
isolates with wide geographic distribution and long
epidemiological histories in a given population [3].
Whole genome sequencing (WGS) directly overcomes
these limitations and has rapidly become an important,
if not central, research tool in TB epidemiology: WGS-
based studies have detected previously unknown
outbreak clusters among isolates with identical MIRU-
VNTR types [5, 6] and identified so-called super-
spreaders responsible for multiple secondary infections
in the community [7]. In addition, an expanding body of
work has employed WGS data to address a wide-
reaching set of previously uninvestigated questions in M.
tuberculosis evolution and population genomics [8–11].
Next-generation WGS technologies have markedly de-
creased per-isolate sequencing costs, and are expected to
replace many current modalities in public health micro-
biology [12, 13]. Specific applications of interest for TB
control include rapid drug resistance typing, locating
cryptic outbreak clusters and transmission hotspots not
identified via field epidemiology, and identification and
tracking of novel M. tuberculosis strains in the commu-
nity. SNP-distance based strategies have proven useful
for identifying recent TB transmission [5] and WGS data
has allowed for unprecedented phylogenetic resolution
between and within M. tuberculosis subpopulations.
Population genomics studies in both M. tuberculosis and
other pathogens have established important linkages
between the evolutionary and epidemiological histories
of endemic and/or emerging pathogen subpopulations
[14, 15]. Specifically, emerging M. tuberculosis subpopu-
lations are expected to exhibit low sequence diversity, an
excess number of high frequency derived alleles, and
potentially harbor strain-specific patterns of positive or
purifying genomic selection.
Multiple M. tuberculosis strains have emerged from
New York City and neighboring New Jersey (NYC-NJ)
over the last two decades. For example, M. tuberculosis
isolates from the S75 group, a low-IS6110 copy number
strain first identified in New Jersey, USA [16] in 2002,
circulate within the NYC-NJ area, predominantly among
HIV-positive and homeless populations [17]. The drug-
susceptible C strain was first reported in NYC, where it
has caused outbreaks among at-risk populations and
sporadic cases in the general population, and then
spread widely across the United States [3]. Both C and
S75 strains belong to M. tuberculosis Lineage 4, the most
widely distributed and successful of the six M. tubercu-
losis global phylogeographic lineages [18] and the most
prevalent lineage in the New York City area.
This study uses WGS data from TB isolates collected
in New York City and New Jersey between 1999 and
2009, applying both phylogenomic and population gen-
omics methods to identify epidemiologically-relevant
subpopulations within this relatively monomorphic local
population. These methods identify previously known
subpopulations (including S75) retrospectively, suggest
useful measures for prospective and real-time identifi-
cation of newly emerging isolate groups, and yield
additional information on adaptation and epidemio-




Seventy one total M. tuberculosis full genome sequences
were included in this study. Fourty-seven isolates from
Lineage 4 were included: 32 isolates from TB cases oc-
curring in New York City and New Jersey between 1997
and 2009, including 9 S75 isolates; 9 additional clinical
isolates from Sub-Saharan Africa [19, 20] and North
America [21]; and 6 well-characterized laboratory strains
[20, 22–24]. Two additional isolates from New York
City, from Lineage 1 and Lineage 3, were also sequenced
for this study. Sequence data for 19 additional non-L4
isolates, plus 3 isolates from the M. africanum-like
Lineage 6 and the outgroup M. bovis, were obtained from
publicly available sources (Additional file 1: Table S1).
Sequencing, alignment, and SNP calling
WGS data were obtained for 34 previously-unsequenced
M. tuberculosis clinical isolates (Table 1). Isolates were
cultured on Löwenstein-Jensen slants and grown at 37 °C
for 3–5 weeks. Sequencing libraries were prepared using
TruSeq DNA or Nextera DNA preparation kits
(Illumina, San Diego, CA). Raw sequencing reads
were generated on the Illumina HiSeq 1000 platform
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and aligned to the H37Rv reference genome
(NC_000962.2) using the Burrows-Wheeler Aligner
[25]. Genome assemblies for all isolates were depos-
ited in the NCBI Genbank database (accession
numbers are listed in Table 1). All isolates had reads
covering >99% of the reference genome, and the
lowest mean coverage depth for any isolate was 27×.
SNPs were called using a PHRED-scaled quality
threshold of 40 (Samtools v0.1.19 [26]) and
annotated using snpEff v4 [27]. We excluded from
analysis all variants occuring within PE and PPE
genes, a family of highly repetitive, GC-rich M.tuber-
culosis genes in which recombination has been
observed [28].
Availability of data and materials
The dataset supporting the conclusions of this article is
available in the NCBI Genbank repository (http://
www.ncbi.nlm.nih.gov, BioProject: PRJNA288586) and
supporting sequence alignments and phylogenetic tree
data are available on TreeBASE.
Table 1 Characteristics of the isolates sequenced in this study
Isolate Lineage Location Year Reads Mean read depth %Genome coverage Filtered SNPs Genbank Accession
BE_116771 1 NJ 1999 2,883,388 31.633 0.994 2065 LKMF01000000
BE3_11657 3 NJ 1999 2,934,017 63.728 0.996 1046 LKDN01000000
001_13432 4 NYC 2000 3,027,826 75.362 0.996 1060 LKDO01000000
AH_14271 4 NYC 2001 4,045,981 95.556 0.998 1074 LKDP01000000
AH26_26663 4 NYC 2010 1,356,722 33.169 0.997 1044 LJIQ01000000
AH26_28866 4 S. Africa 2011 1,958,645 23.009 0.994 968 LKMH01000000
AU_8623 4 NYC 1998 6,294,738 71.734 0.996 983 LKMG01000000
BE_10225 4 NJ 1999 1,896,522 47.939 0.994 1049 LJIK01000000
BE_13443 4 NYC 2001 3,669,247 91.597 0.995 1071 LKDQ01000000
BE_14248 4 NYC 2001 2,921,250 70.22 0.995 1077 LKDR01000000
BE_7556 4 NJ 1997 3,580,176 41.681 0.995 961 LJIL01000000
C_913 4 NYC 1992 14,910,476 387.981 0.995 1101 LKMI01000000
C_10367 4 NYC 1999 2,082,141 51.722 0.995 1057 LJIP01000000
C_14229 4 NYC 2001 5,108,155 127.485 0.996 1128 LKDS01000000
C130 4 NYC 1991 2,704,576 64.086 0.996 1057 LJIN01000000
C24_20545 4 NYC 2005 2,856,851 71.852 0.997 1125 LJIM01000000
C28_9319 4 NJ 1998 2,179,814 53.922 0.995 1058 LJIO01000000
C28_9904 4 NJ 1999 1,632,080 39.971 0.994 1019 LJIR01000000
C30_19588 4 NYC 2004 4,631,768 115.895 0.996 1083 LKDT01000000
C34_13853 4 NYC 2001 2,008,488 48.272 0.995 1048 LKHH01000000
C4_16679 4 NYC 2002 3,966,004 96.262 0.996 1075 LKIF01000000
C49_20090 4 NYC 2005 1,966,774 47.421 0.995 1024 LKIG01000000
C53_20899 4 NYC 2006 3,105,243 74.778 0.994 1062 LKIH01000000
H_13559 4 NYC 2001 3,185,904 76.306 0.996 1041 LKII01000000
H_13571 4 NYC 2001 1,815,449 44.429 0.995 1021 LKIJ01000000
H_7300 4 NYC 1997 2,011,143 48.599 0.994 1020 LKDL01000000
H55_24991 4 NYC 2009 1,743,190 42.094 0.995 1041 LKIK01000000
H6_10443 4 NJ 1999 1,799,336 43.72 0.995 1019 LKIL01000000
H6_12226 4 NJ 2000 4,457,191 105.789 0.996 1074 LKIM01000000
H6_7420 4 NJ 1997 1,719,494 43.153 0.994 1041 LKDM01000000
I_15762 4 NYC 2002 2,785,341 66.101 0.995 1057 LKIN01000000
KI_19771 4 NYC 2004 2,884,815 69.225 0.995 1079 LKIO01000000
L_13621 4 NYC 2001 8,967,725 221.783 0.997 1098 LKIP01000000
V_13678 4 NYC 2001 1,517,250 35.643 0.997 1018 LKIQ01000000
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Phylogenetic reconstruction
Phylogenetic trees were estimated using maximum
likelihood methods in the POSIX-threads build of
RAxML v8 [29]. Node robustness was assessed with
1000 bootstrap pseudoreplicates and a consensus
network was calculated [30] as implemented in Split-
sTree v4.3.1 [31]. A custom Perl script was used to
identify SNPs with alleles unique to a given lineage or
subpopulation.
Neutrality statistics and selection analysis
Neutrality statistics (including Tajima’s D, Fu and Li’s D
and F, Ramos-Onsins and Rozas’s R2, and Fay and Wu’s
H) were calculated in DnaSP v5.10.1 [32] with statistical
significance assessed with 10,000–50,000 coalescent
simulations. Fay and Wu’s H is particularly useful for
distinguishing whether a given departure from neutrality
is attributable to recent population expansion or a
selective sweep [33]. The gene-wise ratio of the nonsy-
nonymous substitution rate to the synonymous substitu-
tion rate (dN/dS) was estimated for every gene in the M.
tuberculosis genome across all phylogenetic branches
using the branch-site random effects likelihood (BSREL)
model as implemented in HyPhy v2 [34, 35]. This model
tests for branch-specific instances of episodic diversify-
ing selection on every internal and terminal branch on
the phylogenetic tree (in this case for every single gene
fitted on the phylogenomic tree) and, following a
likelihood-ratio test and Holm’s correction for multiple
tests, detects branches on which a proportion of the co-
dons have evolved under a dN/dS ratio that is signifi-
cantly different from that of the rest of the codons. The
advantage of this model over other so-called branch-site
models is that it does not constrain the tree on either
sides of the branch being tested to be subject to diversi-
fying selection (foreground branches) and purifying
selection (background branches).
Results
Population structure and genetic diversity
Maximum likelihood phylogenomic reconstruction
based on 14,601 quality-filtered SNPs recovered primary
phylogeographic Lineages 1–6 and identified at least six
distinct subpopulations within L4 isolates, including S75.
Nucleotide diversity (π, the mean number of pairwise
nucleotide differences per site [36]) ranged from 1.5E-5
to 1.7E-4 (Table 2), consistent with prior estimates of
genetic diversity within coding regions of the M. tuber-
culosis genome [19]. S75 strains were separated from
any other L4 isolate by at least 143 SNPs and exhibited
lower nucleotide diversity and lower mean pairwise SNP
distances between isolates (66.4 vs. 392.8 SNPs for NYC
isolates not in the S75 cluster).
Drug resistance-associated polymorphisms
Polymorphisms at drug resistance-associated codon sites
were evaluated for 36 known drug resistance genes
(Additional file 2: Figure S1). Mutations in katG, which
confer resistance to isoniazid, were common among iso-
lates from Lineages 1–3, 5, and 6 and L4 isolates from
western and sub-Saharan Africa, and rare among L4 iso-
lates from N. America and Europe, occurring in only a
single isolate from this group. S75 isolates were found to
have a strain-specific mutation in embA (Ala462Val) pre-
viously associated with ethambutol resistance [37], how-
ever the S75 isolates included in this study are
ethambutol-sensitive. L4 isolates from Kwazulu-Natal,
South Africa carried drug resistance-associated muta-
tions in katG, rpoB, pncA, and rrs, consistent with prior
studies on these drug-resistant isolates [38].
Subgroup-defining polymorphisms
One hundred seventeen synapomorphic SNPs (i.e. loci at
which isolates in given subgroup carry one allele and all
isolates outside the subgroup carry a different allele)
Table 2 Genetic diversity and neutrality test statistics by lineage (L1-L4)
Lineage N S π DT DFL FFL R2 HFW HnFW






























N, number of ingroup sequences; S, number of segregating sites; π, nucleotide diversity; k, average number of nucleotide differences; DT, Tajima’s D; R2,
Ramos-Onsins and Rozas’ R2, DFL and FFL, Fu and Li’s D and F (calculated with M. bovis as an outgroup); HFW, Fay and Wu’s H; HnFW, Fay and Wu’s normalized H. Statistical
significance was assess with 10,000 coalescent simulations (50,000 simulations for R2). *P < 0.05, **P < 0.005
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differentiate L4 isolates from the non-L4 isolates in-
cluded in this study (Fig. 1). Seventy-five additional
SNPs differentiate North American isolates (isolates
distal to Node a in Fig. 2, including those from New
York, New Jersey, and the CDC1551 outbreak strain)
from non-North American isolates, and 16 SNPs differ-
entiate S75 from other North American isolates. Synapo-
morphic SNPs are unequally distributed by functional
category, predominantly occurring in genes associated
with cell wall functions, lipid metabolism, respiration,
and intermediary metabolism. Non-synonymous synapo-
morphic SNPs occur in multiple genes with known or
proposed functions in virulence, growth, and/or adapta-
tion, including known virulence factors (mce1A, mce2C,
vapC40, vapC38, otsA, yrbE2B, and cstA [39–43]), and
also components of gene-regulatory (sigJ, ramB), lipid
metabolism (pks5, fadD15, Rv3087), intermediary me-
tabolism (lpdA), and cell-wall associated pathways
(eccC4) with known or proposed functions in M. tuber-
culosis virulence [44–50]. New York City and S75 iso-
lates carry a unique non-synonymous mutation in
Rv1290c, a conserved gene of unknown function that
when disrupted causes a severe attenuation of virulence
[51]. Additional file 3: Table S2 lists the complete set of
subgroup-defining SNPs.
Neutrality test statistics and population size expansion
Site frequency-based neutrality test statistics were calcu-
lated using whole-genome polymorphism data by lineage
(L1-L4) and by subgroups within L4, including the S75
outbreak cluster and non-S75 isolates from New York
City and New Jersey (Table 2) Tajima’s D (DT) and Fu &
Li’s D and F test statistics (DFL and FFL), were signifi-
cantly negative when calculated for all L4 isolates as a
group (n = 47) and for the subgroup of non-S75 isolates
from New York City. Negative values for DT, DFL, and
FFL indicate a relative excess of low frequency alleles in a
population, which can occur following recent population
expansion or a selective sweep [52]. Fay and Wu’s H, a
statistic that is insensitive to population expansion but
highly sensitive to selection pressure, was not signifi-
cantly different from zero for all isolate subgroups,
suggesting that population expansion–rather than a
selective sweep–explains the relative excess of rare
alleles in isolates in L1-3 and non-S75 L4 isolates.
Significant values for Ramos-Onsins & Rozas’ R2 statis-
tic, which tests for recent population size expansion
based on the difference between the number of singleton
mutations and the mean number of nucleotide differ-
ences between samples, were observed for all subgroups
except S75. All five neutrality test statistics were non-
significant for the S75 outbreak cluster. Unlike other
subgroups, the unfolded site frequency spectrum for S75






Fig. 1 Synapomorphic polymorphisms by functional category and
isolate subgroup. a Virulence and adaptation, b Regulatory and
information pathways, c Conserved proteins without known function,
d Cell wall and lipid metabolism, e Intermediary metabolism and
respiration. L4 includes all (n = 47) Lineage 4 isolates included in this
study, NYC-NJ (N = 32) includes L4 isolates collected in New York City
or New Jersey, USA, including the S75 outbreak cluster, and S75 (N = 9)
includes isolates belonging the New Jersey outbreak cluster described
in the text. Genes carrying diagnostic SNPs with known functions in
virulence, growth, and/or adaptation are listed above each column,
and of these genes, those with non-synonymous polymorphisms are
highlighted in yellow. The number of total diagnostic SNPs unique to
S75 (which includes those unique to L4 and NYC-NJ) are listed in the
third column
Brown et al. BMC Genomics  (2016) 17:947 Page 5 of 11
and negative values for Fay and Wu’s H and normalized
H, consistent with a small but non-significant excess of
high-frequency derived alleles in this subpopulation.
Purifying selection on genes involved in lipid metabolism
and cell wall maintenance
dN/dS was significantly less than 1, consistent with puri-
fying selection, for two genes in lipid metabolism path-
ways and five putative transmembrane protein genes
(Supplementary Table S1). Two lipid metabolism path-
way components, phenolphthiocerol synthesis polyketide
synthase A–E family (ppsA) and polyketide synthase 12
(pks12), exhibited significantly decreased dN/dS in a
specific subpopulation of New York City isolates (at
nodes b, c, and d in Fig. 2). Evidence of episodic diversi-
fying selection, with dN/dS significantly greater than 1,
was limited to three isolates in our study, the L2 isolate
W148, the L1 isolate T17, and the M. africanum K85
isolate.
Discussion
M. tuberculosis exhibits very low sequence diversity
compared to other bacteria, minimal evidence of hori-
zontal gene transfer [53–55], and recombination limited
to known highly variable gene families [28]. This lack
of genetic diversity is pronounced in geographically
restricted M. tuberculosis populations, such that
locally endemic clone groups have posed a unique
A
B
Fig. 2 a Consensus network of 1000 maximum likelihood bootstrap replicates for Mycobacterium tuberculosis isolates from North America,
Sub-Saharan Africa, and Asia (n = 71) based on 14,601 SNPs. Branches are color-coded by lineage. Isolates from the S75 cluster, identified
in New Jersey in 1997–2001, are highlighted; b World map of isolate collection locations color-coded by lineage
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challenge to laboratory-based identification of TB out-
break clusters in New York City. Historically, these
isolates have been strongly associated with homeless
and at-risk populations, in which field epidemiology
and contact tracing are often difficult, placing a pre-
mium on rapid and reliable laboratory identification
of clustered cases. In one case series, 52% of patients
infected with C strain isolates in NYC had no phone
number or address, or could otherwise not be con-
tacted by public health investigators [17]. The present
study demonstrates how whole genome-based labora-
tory analysis can overcome these challenges, and sug-
gests that WGS may be a particularly important tool
at the local level, where genetic diversity is expected
to be lower compared to more geographically diverse
samples. The results presented here provide three
specific approaches for identifying outbreak clusters
and emerging strain groups in local M. tuberculosis
populations: (1) genome-based phylogenetic recon-
struction; (2) population genetic analysis, specifically
estimation of neutrality and diversity statistics within
grouped samples; and (3) genome-wide analysis for
distinguishing signatures of purifying or diversifying
selection.
Whole genome-based phylogenetic reconstruction
yielded clearly defined population substructure among
locally-endemic isolates in the New York City area,
and identified S75 isolates as distinct clade in the
phylogeny. S75 isolates also exhibited poorly differen-
tiated terminal branching patterns, and relatively
lower bootstrap support at individual nodes, which
may reflect the limits of phylogenetic resolution in-
herent to available genome sequencing data. Although
this approach allows for robust retrospective identifi-
cation of outbreak clusters and emerging strain
groups, it is perhaps less well suited for rapid identifi-
cation of clustered transmission among new TB cases,
in which low levels of genetic differentiation may
preclude high-confidence phylogenomic resolution
between isolates. However, as WGS-based technologies
replace conventional genotyping methods, phylogenetic
reconstruction will likely become an important tool in
public health microbiology, providing a “phylogenetic
reference” for TB isolates sequenced within a given
geographic area or TB control program [56]. In addition,
clustering of incident isolates in a specific phylogenetic
branch could suggest ongoing transmission within a
specific at-risk population.
SNP distance-based inference of recent transmission,
in which the pairwise SNP distance is used to infer
whether two isolates were transmitted directly between
their respective hosts, is likely to become an important
epidemiological tool in TB control [7, 57]. Although the
distribution of pairwise SNP differences is expected
to vary between low- and high-transmission areas
(with higher average pairwise SNP differences ex-
pected in high-transmission settings and in areas
with lower TB case notification rates) [58], emerging
M. tuberculosis subpopulations are still expected to
exhibit relatively few SNP differences between iso-
lates. Identification of subpopulation-defining synapo-
morphic polymorphisms can support this approach
by identifying unique SNPs shared between isolates
in emerging subpopulations.
The two additional methods used in this study (esti-
mation of neutrality and diversity statistics and selec-
tion analysis) are likely to have more value in
retrospective analyses, where they can yield useful
information about the epidemiological and evolution-
ary history of circulating M. tuberculosis subpopula-
tions. Subgroup-defining polymorphisms can provide
useful genetic markers for M. tuberculosis strain iden-
tification, similar to other minimal SNP sets used in
M. tuberculosis phylogenetics [59]. S75 isolates in this
study could be distinguished from other North
American isolates using only 16 SNPs, and determin-
ation of similar subgroup-defining SNP sets could
provide a straightforward tool for rapidly determining
Fig. 3 Unfolded site frequency spectra for isolates from the S75 outbreak cluster (L4:S75) and non-S75 isolates from the New York City area.
Dark and light blue bars indicate the number of non-synonymous and synonymous SNPs at each SNP allele frequency (from singletons on the
left to SNPs at fixation on the right)
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if a given TB isolate belongs to an existing outbreak
cluster or endemic strain group. More broadly,
subgroup-defining polymorphisms also provide inter-
esting, if limited, insight into the evolutionary history
of Lineage 4M. tuberculosis isolates in North America
and the specific L4 populations endemic to New York
City. Isolates in these populations have only a min-
imal number of drug resistance-associated mutations,
and instead have acquired multiple non-synonymous
SNPs in virulence- and growth-associated pathways.
Mutations in pks5 and yrbE2B are of particular inter-
est, first because of their well-characterized roles in
M. tuberculosis virulence and second because they
may both influence TNF-mediated host immune
responses [39, 44]. S75 isolates strains are known to
induce higher levels of TNF-α in vitro [60], which
may help explain why S75 isolates have spread prefer-
entially in immunocomproised patients. Although the
functional consequences of these mutations are still
unknown, these findings suggests that overall pathoa-
daptive fitness, rather than the acquisition of drug
resistance mutations, may have played an important
role in the evolutionary history of L4 M. tuberculosis
populations in New York City.
Selection analysis identified two loci in M. tubercu-
losis lipid metabolism pathways, ppsA and pks12,
with significantly decreased dN/dS ratios consistent
with evolution under strong purifying selection. Ob-
serving signatures of purifying selection localized to
a single subpopulation (in this case, the M. tubercu-
losis isolates grouped under Nodes b, c, and d), may
suggest adaptation to a particular subpopulation or
transmission niche, and thus provide useful informa-
tion about risk factors for acquisition of infection
with an emerging strain group. ppsA and other pps
family genes are involved in the synthesis of phthio-
cerol and phenolphthiocerol, two components of cell
wall lipids unique to pathogenic mycobacteria that
likely participate in host-pathogen interactions [61]
and virulence [62, 63]. Interestingly, Farhat et al.
identified ppsA and pks12 among 39 genes that ex-
hibit signatures of convergence and possible positive
selection in multidrug-resistant M. tuberculosis iso-
lates [64]. Although these loci may exhibit signatures
of positive selection in drug-resistant populations, it
is not unexpected that ppsA and pks12 would exhibit
signatures of purifying selection in populations with-
out a similar history of drug selection pressure. Con-
sistent with this hypothesis we observed relatively
fewer drug resistance-associated mutations in the
same subpopulations where ppsA and pks12 exhibit
signatures of purifying selection. Furthermore we
found that dN/dS ratios at known drug-resistance
loci were not significantly greater than one in our
sample, consistent with prior studies in drug-
susceptible M. tuberculosis isolates [65]. The dN/dS
ratio has limited power to detect positive selection in
recently diverged intraspecific sequences and may
underestimate the magnitude of negative selection in
genes under strong purifying selection [66]. However,
because the dN/dS ratio is expected to underestimate
the magnitude of the selection coefficient in this
context, our analysis is likely conservative, and the
true magnitude of negative selection on ppsA and
pks12 may be larger than we have reported.
Lastly, estimation of multiple neutrality statistics
yielded evidence for past population expansion across
multiple subpopulations, consistent with prior studies
on demographic expansion in M. tuberculosis popula-
tions [10, 67], with the notable exception of S75. This
finding, in conjunction with the negative but nonsig-
nificant H values estimated for S75 isolates (indicating
an excess of high-frequency derived alleles), is con-
sistent with the epidemiological history of this re-
cently diverged group of closely related isolates.
However, it is important to acknowledge that factors
such as sample size and time since demographic ex-
pansion can influence the power of statistics that
draw from the site frequency spectrum to detect past
population growth. Specifically, site frequency
spectrum-based statistics may fail to detect population
expansion if the elapsed time since an expansion is
either too small or too large, or with small sample
sizes [52], and thus may be less useful for identifica-
tion of emerging strain groups, as illustrated here.
Importantly, the retrospective sample used in this
study includes less than 0.01% of all M. tuberculosis
infections occurring in New York City between 1999
and 2009 [2]. Nevertheless, this study demonstrates
that even a small sample of isolates can yield mean-
ingful information about the epidemiological and evo-
lutionary history of endemic M. tuberculosis isolate
groups in low-transmission settings.
Conclusions
WGS-based technologies are likely to replace many
conventional genotyping methods currently used in
public health microbiology and TB epidemiology.
How to maximize the public health value of this
paradigm shift, and the large quantities of genomic
data it will soon make available, is still an open ques-
tion. Whole genome-based drug resistance profiling,
SNP distance-based methods to identify ongoing
transmission, and phylogenetic reconstruction will
likely yield the most direct, practical benefits, and the
WGS data collected during these activities will pro-
vide an important resource for ongoing research in
TB epidemiology and pathogen evolution.
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Additional files
Additional file 1: Table S1. Complete list of non-synonymous and
synonymous synapomorphic polymorphisms for all L4 isolates, L4 isolates
from New York City and New Jersey, and isolates from the S75 outbreak
cluster. (DOCX 19 kb)
Additional file 2: Figure S1. Whole-genome maximum likelihood
phylogenetic reconstruction of Mycobacterium tuberculosis isolates from
North America, Sub-Saharan Africa, and Asia (n = 71). Values at the nodes
indicate branch support based on 1000 bootstrap replicates. Letter labels
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